Phase II Study of Cetuximab Anti-Epidermal Growth Factor Receptor (EGFr) Antibody in Combination With Chemotherapy in Patients With Metastatic or Recurrent Squamous Cell Head and Neck Carcinoma.
Phase of Trial: Phase II
Latest Information Update: 23 Jun 2009
At a glance
- Drugs Cetuximab; Cisplatin; Fluorouracil; Paclitaxel
- Indications Head and neck cancer; Squamous cell cancer
- Focus Adverse reactions; Therapeutic Use
- 06 Mar 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Feb 2009 ImClone Systems added as trial affiliate and sponsor as reported by ClinicalTrials.gov.
- 20 Sep 2005 New trial record.